Literature DB >> 35132591

Origin and Structural Biology of Novel Coronavirus (SARS-CoV-2).

Rahul Mallick1, Asim K Duttaroy2.   

Abstract

INTRODUCTION: A recent rapid outbreak of infection around the globe has been caused by a novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in December 2019 in Wuhan city of Hubei province, People's Republic of China.
METHODS: We reviewed the currently available literature on coronaviruses.
RESULTS: Coronaviruses are a group of enveloped viruses with non-segmented, single-stranded, and positive-sense RNA genomes. Although 13 variation sites in open reading frames have been identified among SARS-CoV-2 strains, no mutation has been observed so far in envelop protein. The origin and structural biology of SARS-CoV-2 in details are discussed.
CONCLUSIONS: Origin and structural biology will help the researchers identify the virus's mechanism in the host and drug design. Currently, no clinical treatments or prevention strategies are available for any human coronavirus.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  ACE2; COVID-19; Furin-like cleavage site; Heparan sulfate proteoglycans; Open reading frame; Polyproteins; Receptor binding domain; S1/S2 cleavage site; S2′ cleavage site; SAR-CoV-2; Spike protein; non-structural proteins

Mesh:

Substances:

Year:  2021        PMID: 35132591     DOI: 10.1007/978-3-030-85109-5_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

Review 1.  The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis.

Authors:  Ruth McBride; Burtram C Fielding
Journal:  Viruses       Date:  2012-11-07       Impact factor: 5.048

  1 in total
  2 in total

Review 1.  Animal models for COVID-19: advances, gaps and perspectives.

Authors:  Changfa Fan; Yong Wu; Xiong Rui; Yuansong Yang; Chen Ling; Susu Liu; Shunan Liu; Youchun Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

2.  Can plant-derived anti-HIV compounds be used in COVID-19 cases?

Authors:  Diptimayee Das; Atala Bihari Jena; Antara Banerjee; Arun Kumar Radhakrishnan; Asim K Duttaroy; Surajit Pathak
Journal:  Med Hypotheses       Date:  2022-08-03       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.